Mechanisms associated with neuroprotection from Mn-induced neurotoxicity.
与锰诱导的神经毒性的神经保护相关的机制。
基本信息
- 批准号:10062730
- 负责人:
- 金额:$ 54.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-10 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAdverse effectsAlzheimer&aposs DiseaseAnimal DiseasesAntioxidantsApoptosisAttenuatedBCL2 geneBindingBrainCellsChronicClinical ResearchCognitive deficitsDataDevelopmentDiseaseDopamineEnzymesEpigenetic ProcessEstradiolEstrogen Receptor alphaEstrogen ReceptorsExperimental ModelsExposure toExpression ProfilingFemaleFoundationsFunctional disorderGPER geneGene ExpressionGenesGenetic TranscriptionGenomicsHumanIn VitroInflammationInjuryLeadLearningManganeseMediatingMediator of activation proteinMemoryMolecularMolecular TargetMusNeurodegenerative DisordersNeurogliaNeuronal DysfunctionNeuronal InjuryNeuronsOutcome StudyOxidative StressParkinson DiseasePathologicPathway interactionsPeripheralPharmacologyPhenotypePlayRE1-silencing transcription factorRepressionRisk FactorsRoleSelective Estrogen Receptor ModulatorsSignal TransductionSymptomsTYRP1 geneTamoxifenTechnologyTestingTherapeuticToxic effectTyrosine 3-MonooxygenaseUp-RegulationYin-Yangagedcatalasecombatdementia riskdopaminergic neuronestrogenicfemale sex hormonein vivoinsightmalemalignant breast neoplasmnervous system disorderneuroprotectionneurotoxicitynigrostriatal pathwaynon-genomicnoveloverexpressionpromoterprotective effectrecruitrestorationtranscription factorvector
项目摘要
Project Summary
Chronic exposure to high levels of manganese (Mn) causes manganism, a neurological disorder
which shares multiple pathological features with Parkinson's disease (PD). Mn-induced
neurotoxicity includes decreased expression of tyrosine hydroxylase (TH), a rate-limiting enzyme
in dopamine synthesis, and dopaminergic neuronal injury. But the mechanisms of the Mn-induced
neurotoxicity are not completely understood. Estrogenic compounds, such as tamoxifen, a
selective estrogen receptor modulator (SERM), have been shown to be protective in Mn toxicity
and PD, but their mode of action remains to be established. While the transcription factor RE1-
silencing transcription factor (REST) was initially described as a repressor of neuronal genes in
non-neuronal cells during development, it has recently been shown to play a critical role in
protection of adult neurons, and it activates genes that are involved in neuroprotection. Our
preliminary data reveal that Mn decreased REST, whereas TX increased its expression in TH-
expressing neuronal cells. REST protected dopaminergic neurons against Mn neurotoxicity by
attenuating Mn-induced oxidative stress, inflammation and apoptosis. These findings indicate that
REST may mediate TX-induced neuroprotection against Mn toxicity in dopaminergic neurons.
Therefore, investigating the mechanisms of REST in Mn-induced neurotoxicity and TX-induced
protection against Mn toxicity is critical to advance our understanding of Mn neurotoxicity and in
developing therapeutic strategies to treat neurodegenerative diseases associated with
dysfunction of dopaminergic neurons. We hypothesize that REST protects against Mn
neurotoxicity by enhancing expression of TH, as well as the antioxidant/antiapoptotic genes
catalase (CAT) and B-cell lymphoma 2 (Bcl-2), and mediates TX-induced protection against Mn
toxicity via genomic ERα and nongenomic ERα/GPR30 pathways. Our hypothesis will be tested
in the following specific aims: 1) Test if REST in DAergic neurons is protective against Mn
neurotoxicity in mice, 2) Investigate mechanisms of Mn-induced REST reduction and the
protective effects of REST against Mn neurotoxicity via upregulation of TH, CAT and Bcl-2, and
3) Test if DAergic REST is a critical mediator of TX-induced neuroprotection against Mn toxicity.
The outcome of the study will provide critical information on the role of REST in DAergic neuronal
function, Mn toxicity and TX-induced neuroprotection against Mn toxicity. The results also greatly
contribute to the development of `neuroSERMs' to treat NDs associated with DAergic injury, such
as manganism and potentially PD.
项目摘要
长期暴露于高水平的锰(MN)会导致锰(一种神经系统疾病)
它与帕金森氏病(PD)具有多种病理特征。
神经毒性包括降低酪氨酸羟化酶(TH)的表达,速率限制酶
在多巴胺合成和多巴胺能神经元损伤中。
神经毒性不是化合物,是他莫昔芬的性别
选择性雌激素受体改装剂(SERM)
和PD,但动作方式仍有待确定。
沉默转录因子(静止)最初被描述为神经元基因的阻遏物
开发过程中非神经元细胞,最近已证明它在
我们的
初步数据启示了Mn减少休息,而TX则增加了其在TH-中的表达
表达神经元细胞。
减弱MN诱导的氧化应激,炎症和炎症。
REST可能介导TX诱导的对多巴胺能神经元中MN毒性的神经保护作用。
因此,研究MN诱导的神经毒性和TX诱导的静止机制
防止Mn毒品的保护,以促进我们对Mn神经毒性的理解
制定治疗策略以信任与之相关的神经退行性疾病
多巴胺能神经元的功能障碍。
神经毒性通过增强Th的表达以及抗氧化剂/抗抑制剂基因
过氧化氢酶(CAT)和B细胞淋巴瘤2(BCl-2),以及介导TX诱导的对MN的保护
通过基因组ERα和非基因组ERα/GPR30途径的毒性。
在以下特定目的中:1)测试是否在Daergic神经元中休息是保护性MN
小鼠的神经毒性,2)研究MN诱导的休息降低的机制和您
通过上调TH,CAT和BCL-2和2
3)测试Daergic REST是否是TX诱导的针对MN毒理的神经保护作用的关键介体。
研究的结果提供了有关静止作用在DAERMER元中的作用的关键信息
功能,MN毒剂和TX诱导的神经保护作用也很大。
为处理与Daergic损伤相关的NDS的发展做出贡献
作为锰和电力PD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eun Sook Yu Lee其他文献
Eun Sook Yu Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eun Sook Yu Lee', 18)}}的其他基金
Mechanisms associated with neuroprotection from Mn-induced neurotoxicity.
与锰诱导的神经毒性的神经保护相关的机制。
- 批准号:
10415153 - 财政年份:2020
- 资助金额:
$ 54.32万 - 项目类别:
Mechanism of manganese-induced impairment of astrocytic glutamate transporters
锰引起星形胶质细胞谷氨酸转运蛋白损伤的机制
- 批准号:
8964605 - 财政年份:2015
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
星形胶质细胞 Glu 转运蛋白通过 TGF-a/b1 发挥雌激素神经保护作用
- 批准号:
8476230 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
星形胶质细胞 Glu 转运蛋白通过 TGF-a/b1 发挥雌激素神经保护作用
- 批准号:
8088147 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TFG-a/bl
星形胶质细胞 Glu 转运蛋白通过 TFG-a/bl 产生雌激素神经保护作用
- 批准号:
9370091 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
星形胶质细胞 Glu 转运蛋白通过 TGF-a/b1 发挥雌激素神经保护作用
- 批准号:
8669005 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
星形胶质细胞 Glu 转运蛋白通过 TGF-a/b1 发挥雌激素神经保护作用
- 批准号:
7762128 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
星形胶质细胞 Glu 转运蛋白通过 TGF-a/b1 发挥雌激素神经保护作用
- 批准号:
8269823 - 财政年份:2010
- 资助金额:
$ 54.32万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
$ 54.32万 - 项目类别:
A novel therapeutic approach for Alzheimer Disease (AD)
阿尔茨海默病(AD)的新治疗方法
- 批准号:
10740016 - 财政年份:2023
- 资助金额:
$ 54.32万 - 项目类别:
KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
KLOTHO 和临床前 AD 中突触功能障碍的恢复力
- 批准号:
10587987 - 财政年份:2023
- 资助金额:
$ 54.32万 - 项目类别:
Neural Mechanisms for Associations Between Fitness and Cognition in Aging
衰老过程中体能与认知之间关联的神经机制
- 批准号:
10913650 - 财政年份:2023
- 资助金额:
$ 54.32万 - 项目类别:
Seizure, cognitive change and dementia: Understanding the use and safety of anti-seizure medications
癫痫、认知改变和痴呆:了解抗癫痫药物的使用和安全性
- 批准号:
10740534 - 财政年份:2023
- 资助金额:
$ 54.32万 - 项目类别: